Saralasin [saralasin]
- Terms
-
(Sar(1),Ala(8))ANGII
(Sar1,Val5,Ala8)Angiotensin II
1-Sar-8-Ala Angiotensin II
1-Sarcosine-8-Alanine Angiotensin II
Angiotensin II, Sar(1)-Ala(8)-
Angiotensin II, Sarcosyl(1)-Alanine(8)-
Sar-Arg-Val-Tyr-Val-His-Pro-Ala
Saralasin Acetate
Saralasin Acetate, Anhydrous
Saralasin Acetate, Hydrated
An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION.
- DUI
- D012504 MeSH Browser
- CUI
- M0019423
- CAS
- Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-
- Previous indexing
- Alanine (1974); Angiotensin II (1974); Sarcosine (1974)
- History note
- 1984(1978)
- Public note
- 1984; see ANGIOTENSIN II 1978-83; 1-SARCOSINE-8-ALANINE ANGIOTENSIN II was indexed under ANGIOTENSIN II 1975-77
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine